help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yokoyama, Y.
Right arrow Articles by Sugino, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yokoyama, Y.
Right arrow Articles by Sugino, H.

Journal of Clinical Endocrinology & Metabolism, Vol 80, 915-921, Copyright © 1995 by Endocrine Society


ARTICLES

Identification of activins and follistatin proteins in human follicular fluid and placenta

Y Yokoyama, T Nakamura, R Nakamura, M Irahara, T Aono and H Sugino
Department of Obstetrics and Gynecology, University of Tokushima, Japan.

Follistatin, an activin-binding protein, is able to neutralize the various activities of activin by forming an inactive complex with it. The widespread tissue localization of follistatin is very similar to that of activin, which suggests that it plays a local modulatory role in the various paracrine/autocrine actions of activin. We detected significant activin-binding activities in human follicular fluid and placental homogenates, although they were much lower than those in porcine and bovine follicular fluids, which raised the possibility that follistatin is present in human follicular fluid and placenta. Therefore, we attempted to identify the protein molecules responsible for this activin-binding activity in human follicular fluid and placental homogenates. Human follicular fluid, collected from in vitro fertilization patients, was processed by affinity chromatography successive steps on sulfated gel matrices and reverse phase high performance liquid chromatography (HPLC). The final HPLC yielded abundant follistatin and almost equimolar amounts of activin-A, -AB, and -B. The follistatin protein showed characteristic multiple bands when analyzed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The ability of each band to bind activin specifically was determined by activin binding assay and ligand blotting analysis. Several pieces of evidence, including the immunoblotting analysis and functional assay results, demonstrated the presence of three activin isoforms, A, AB, and B, in the follicular fluid. In contrast, human placental homogenates were found to contain follistatin and activin-A proteins only. Activin-AB and -B were not detected in any HPLC fraction, indicating that activin-A is the major form of activin in the human placenta. The present data indicate that the three activin isoforms and multiple forms of follistatin exist in human follicular fluid, and the activin-A isoform and follistatin exist in human placenta. They suggest that the physiological functions of the activin isoforms during embryonic development differ and that follistatin plays a functional role in the local control system(s) that regulates human reproduction.


This article has been cited by other articles:


Home page
ReproductionHome page
K Rae, K Hollebone, V Chetty, D Clausen, and J McFarlane
Follistatin serum concentrations during full-term labour in women significant differences between spontaneous and induced labour
Reproduction, November 1, 2007; 134(5): 705 - 711.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
J. A. Keelan, R. L. Zhou, L. W. Evans, N. P. Groome, and M. D. Mitchell
Regulation of Activin A, Inhibin A, and Follistatin Production in Human Amnion and Choriodecidual Explants by Inflammatory Mediators
Reproductive Sciences, September 1, 2000; 7(5): 291 - 296.
[Abstract] [PDF]


Home page
Biol. Reprod.Home page
X. Ni, S. Luo, T. Minegishi, and C. Peng
Activin A in JEG-3 Cells: Potential Role as an Autocrine Regulator of Steroidogenesis in Humans
Biol Reprod, May 1, 2000; 62(5): 1224 - 1230.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
A.E. O'Connor, J.R. McFarlane, S. Hayward, T. Yohkaichiya, N.P. Groome, and D.M. de Kretser
Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study
Hum. Reprod., March 1, 1999; 14(3): 827 - 832.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. S. McConnell, Q. Wang, P. M. Sluss, N. Bolf, R. H. Khoury, A. L. Schneyer, A. R. Midgley Jr., N. E. Reame, W. F. Crowley Jr., and V. Padmanabhan
A Two-Site Chemiluminescent Assay for Activin-Free Follistatin Reveals That Most Follistatin Circulating in Men and Normal Cycling Women Is in an Activin-Bound State
J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 851 - 858.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Petraglia, S. Luisi, C. Benedetto, M. Zonca, P. Florio, E. Casarosa, A. Volpe, S. Bernasconi, and A. R. Genazzani
Changes of Dimeric Inhibin B Levels in Maternal Serum Throughout Healthy Gestation and in Women with Gestational Diseases
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2991 - 2995.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Birdsall, W. Ledger, N. Groome, H. Abdalla, and S. Muttukrishna
Inhibin A and Activin A in the First Trimester of Human Pregnancy
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1557 - 1560.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society